Daily non-political popular news in brief.

Effectiveness of first renin inhibitor drug for treating hypertension is limited

05-09-2007 · EurekAlert!

Hypertension is a serious condition affecting millions. There are seven classes of drugs used to reduce blood pressure. Aliskiren is the first of a new class of antihypertensive drugs that works by inhibiting renin. A review of six large clinical trials of aliskiren is being published in the May issue of the American Journal of Hypertension. The authors report that, because of reactive renin secretion, this drug has not been any more effective than those already widely available.

Keywords: effectiveness, renin, inhibitor, drug, treating, hypertension, limited

« Previous | Next »

Similar news on "Effectiveness of first renin inhibitor drug for treating hypertension is limited":

New angiogenesis inhibitor has promise for treating deadly brain tumor
01-16-2007 · EurekAlert!
Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs.
Similar news · Read more »
Blood-vessel blocker aids cancer-killing virus
11-27-2007 · EurekAlert!
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
Similar news · Read more »
Enzyme may hold key to new treatment of diabetic kidney disease
11-07-2006 · EurekAlert!
Northwestern University researchers have found an enzyme, called "ACE2," may hold the potential to treat diabetic kidney disease, the most common form of kidney disease.The researchers have found low levels of the ACE2 enzyme in kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease.
Similar news · Read more »
Drug blocks lethal motor-neuron disease in mice
02-22-2007 · EurekAlert!
Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations in the gene SMN1 that prevent it producing the protein SMN. New research shows that in a lethal mouse model of SMA the drug trichostatin A (TSA), which is a hydroxamic acid HDAC inhibitor, can improve survival and attenuate disease, indicating that hydroxamic acid HDAC inhibitors might be potential therapeutics for the treatment of individuals with SMA.
Similar news · Read more »
Novel drug preventing protein recycling shows potential for treating leukemia
04-19-2007 · EurekAlert!
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.
Similar news · Read more »
Minimally invasive device shows promise in treating female urinary incontinence
05-22-2007 · EurekAlert!
A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
Similar news · Read more »
Brief motivational interviews work best long term for college students sent to alcohol counseling
07-24-2007 · EurekAlert!
Students who break university rules on alcohol and drug use in residence halls are often sent to counseling or educational programs. Little is known about the long-term effectiveness of these interventions. New findings show that the effects of brief motivational interviews on drinking problems are still apparent 15 months after initiation.
Similar news · Read more »
Anti-inflammatory prevents pancreatic cancer in mice
08-18-2007 · Science News Online
An anti-inflammatory drug of the COX-2 inhibitor family blocks precancerous lesions in mice prone to pancreatic cancer.
Similar news · Read more »
Study shows drug effective in treating, preventing breast cancer
11-01-2007 · EurekAlert!
A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone.
Similar news · Read more »
Model found to determine cause, possible treatment of nerve tumors
02-04-2008 · EurekAlert!
A multi-institutional study led by Cincinnati Children's Hospital Medical Center has led to new insights and a model to help unravel the cause of fibrous, noncancerous nerve tumors called neurofibromas, which can lead to disfigurement and in rare cases death by compressing vital organs. Writing for the February Cancer Cell, researchers said their findings also provide a way to test therapies that could eventually help patients with limited options for treating the disease -- Neurofibromatosis type 1.
Similar news · Read more »